Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Seagen Inc (SGEN)  
$228.74 0.00 (0.00%) as of 4:30 Wed 12/13


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 180,310,000
Market Cap: 41.24(B)
Last Volume: 799,597 Avg Vol: 864,930
52 Week Range: $191.51 - $228.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 39,326 484,602
Total Sell Value $0 $0 $8,245,949 $88,100,996
Total People Sold 0 0 7 8
Total Sell Transactions 0 0 18 70
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 1805
  Page 45 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-11-26 4 OE $12.00 $36,000 D/D 3,000 60,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-11-23 4 S $25.26 $431,100 D/D (17,000) 57,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-11-23 4 OE $12.00 $204,000 D/D 17,000 67,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-11-21 4 S $25.25 $252,500 D/D (10,000) 57,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-11-21 4 OE $15.46 $154,600 D/D 10,000 67,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-11-20 4 S $25.00 $250,000 D/D (10,000) 57,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-11-20 4 OE $12.00 $151,714 D/D 10,000 58,435     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-11-19 4 S $24.90 $249,002 D/D (10,000) 57,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-11-19 4 OE $15.46 $154,600 D/D 10,000 67,601     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2012-11-13 4 S $23.59 $644,724 D/D (27,327) 101,411     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2012-11-13 4 OE $10.29 $255,305 D/D 24,811 126,222     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2012-11-08 4 OE $4.45 $223,107 D/D 34,575 103,927     -
   Simpson Todd E Chief Financial Officer   •       –      –    2012-11-08 4 OE $5.20 $378,412 D/D 72,737 143,499     -
   Siegall Clay B President and CEO   •       •      –    2012-11-01 4 AS $25.51 $210,476 D/D (8,250) 1,170,961     -
   Siegall Clay B President and CEO   •       •      –    2012-11-01 4 OE $3.30 $41,285 D/D 8,250 1,172,961     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2012-10-15 4 AS $25.01 $625,295 D/D (25,000) 69,352     -
   Dobmeier Eric Chief Operating Officer   •       –      –    2012-10-15 4 OE $10.29 $257,250 D/D 25,000 94,352     -
   Siegall Clay B President and CEO   •       •      –    2012-10-01 4 AS $26.59 $219,344 D/D (8,250) 1,170,961     -
   Siegall Clay B President and CEO   •       •      –    2012-10-01 4 OE $3.30 $41,285 D/D 8,250 1,172,961     -
   Himes Vaughn B EVP, Tech. Ops. & Proc. Sci.   •       –      –    2012-09-10 4 S $28.79 $287,900 D/D (10,000) 33,643     -
   Himes Vaughn B EVP, Tech. Ops. & Proc. Sci.   •       –      –    2012-09-10 4 OE $9.23 $92,300 D/D 10,000 43,643     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-09-06 4 AS $29.75 $1,444,065 D/D (48,540) 57,601     -
   Reynolds Thomas C Chief Medical Officer   •       –      –    2012-09-06 4 OE $8.24 $399,970 D/D 48,540 106,141     -
   Simpson Todd E Chief Financial Officer   •       –      –    2012-09-06 4 AS $28.97 $1,448,500 D/D (50,000) 70,762     -
   Simpson Todd E Chief Financial Officer   •       –      –    2012-09-06 4 OE $12.16 $608,000 D/D 50,000 120,762     -
  1805 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 45 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us